Its abnormal expression is associated with cancer development [36], and elevated levels of IGF2BP2 in pancreatic cancer [35, 37], colorectal cancer [38], or esophageal squamous cell carcinoma [34] have been linked to poor prognostic outcomes. Here, IGF2BP2 is linked to familial pancreatic carcinoma.